Related Experiment Videos
Estimating vaccine efficacy from household data observed over time
Xiaohong M Davis1, Michael Haber
1Department of Biostatistics, Rollins School of Public Health, Emory University, 1518 Clifton Road NE, Atlanta, GA 30322, USA.
Statistics in Medicine
|September 8, 2004
Summary
This study introduces a new survival model to accurately estimate vaccine efficacy for susceptibility (VE(S)) and infectiousness (VE(I)) using household data. The improved method offers more stable and robust vaccine effect measurements.
Area of Science:
- Epidemiology
- Biostatistics
- Infectious Disease Modeling
Background:
- Traditional vaccine efficacy estimation focuses on susceptibility (VE(S)).
- Vaccines may also reduce infectiousness (VE(I)), crucial for diseases like HIV.
- Estimating VE(I) is difficult due to exposure data challenges.
Purpose of the Study:
- Develop a robust survival model for estimating VE(S) and VE(I) from household data.
- Improve upon previous methods using only final outbreak data.
- Assess the impact of time-to-event data availability on estimation accuracy.
Main Methods:
- Developed a survival model utilizing time-of-infection data from household studies.
- Employed stochastic simulations to compare the new method with previous approaches.
- Investigated bias from infection status misclassification using illness data.
Main Results:
- The proposed survival model significantly reduces bias and mean square error for VE(S) and VE(I) estimation.
- Household studies with time-to-event data yield more robust estimates than studies of unrelated individuals.
- Misclassification of infection status can introduce bias in VE(S) and VE(I) estimates.
Conclusions:
- A survival model incorporating time-to-event data enhances vaccine efficacy estimation in household studies.
- This method provides more stable and reliable measures of both reduced susceptibility and infectiousness.
- Accurate infection status data is critical for unbiased vaccine efficacy assessment.